Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03970746
Title Safety, Immunogenicity and Preliminary Clinical Activity Study of PDC*lung01 Cancer Vaccine in NSCLC
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors PDC*line Pharma SAS
Indications
Therapies
Age Groups: senior | adult
Covered Countries POL | NLD | FRA | DEU | BEL

Facility Status City State Zip Country Details
Grand Hôpital de Charleroi Charleroi 6000 Belgium Details
Jessa Ziekenhuis Hasselt 3500 Belgium Details
AZ Groeninge Kortrijk 8500 Belgium Details
University Hospitals KU Leuven Leuven 3000 Belgium Details
CHU Liège- Sart Tilman Liège 4000 Belgium Details
AZ Delta vzw Roeselare 8800 Belgium Details
AZ Sint-Nikolaas Sint-Niklaas 9100 Belgium Details
CHU Grenoble Grenoble 38043 France Details
Centre Léon Bérard, Centre de lutte contre le cancer Lyon 69373 France Details
CHU Nantes Nantes 44093 France Details
Universitätsklinikum Franlkfurt Frankfurt am main 60385 Germany Details
Kliniken der Stadt Köln GmbH Köln 51067 Germany Details
Jeroen Bosch Ziekenhuis - 's hertogenbosch 's Hertogenbosch 5223 GZ Netherlands Details
Antoni Van Leeuwenhoek (Nederlands Kanker Instituut) Amsterdam 1066 CX Netherlands Details
Leiden University Medical Center (LUMC) Leiden 2333 ZA Netherlands Details
University Clinical Centre Gdańsk 80-214 Poland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field